us market wants this technology

only one with this in the world and now is patented,if they want it,they have to pay for it.....Phylogica Ltd solidifies international intellectual property suite through key US patent.
Chemical Business NewsBase (Composite) via NewsEdge Corporation :

Phylogica Ltd received formal Notice of Allowance from the US Patent and Trademark Office (USPTO) for its pending application entitled: Isolating Biological Modulators from Biodiverse Gene Fragment Libraries USPTO application 09:568229. This patent secures the second pillar of Phylogica's international intellectual property (IP) suite in the key US market. Phylogica's IP covers the Phylomer libraries as well as the concept of using protein parts from sequenced genomes, other than those of a target protein, to block the interaction of that target protein. Phylogica already has patents covering the method of screening for Phylomers in Australia and the US. Phylomers, which are parts of proteins from Phylogica's proprietary drug discovery libraries, have the potential to block disease protein interactions, providing an alternative to current protein blocking drugs such as antibodies as well as extending the range of protein targets that can be addressed beyond those available to current therapeutic techniques. Phylogica already has a proprietary lead drug candidate product pipeline in this area that is being developed. Phylogica commercialises its proprietary drug discovery technologies developed through a collaboration between the Telethon Institute for Child Health Research in Perth and the Fox Chase Cancer Center in Philadelphia, US.

<